19 July 2023
19 July 2023
AstraZeneca’s Beyfortus becomes the first preventative option specifically designed for infants in their first RSV season.
The acquisition adds an siRNA delivery platform to Novartis’s armament and a potential first-in-class treatment for Charcot-Marie-Tooth Disease.
The European Health Union has issued guidelines to prevent shortages of antibiotics.
The combined company plans to advance Neurogene’s gene therapy pipeline for the treatment of rare genetic disorders.
Flagship and its bioplatform firms are entitled to receive milestone and royalty payments of up to $700m.
Net sales in innovative medicines rose by 9% to $11.2bn during Q2 2023.
The company plans to market the new formulation of vitamin A in 2025.
The "library of libraries" will be licensed by Cancer Research Horizons for a five-year period.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
